Treatment for Cutaneous Candidiasis

First-Line Topical Therapy

• The American College of Physicians recommends applying topical azole antifungals, such as clotrimazole 1% or miconazole 2% cream, twice daily for 7-14 days to immunocompetent patients with cutaneous candidiasis, while keeping the affected area dry, with complete cure rates of 73-100% 1, 2
• Keeping the infected area dry is essential for treatment success, especially in skin fold infections common in obese and diabetic patients 1, 2

Expected Treatment Response

• Improvement in signs and symptoms typically occurs within 48-72 hours of initiating therapy, with mycological cure achieved in 4-7 days, though the full 7-14 day course should be completed 1, 2

Systemic Therapy for Treatment Failures

• If topical treatment fails after 2 weeks, the Infectious Diseases Society of America recommends switching to oral fluconazole 150-200 mg daily for 7-14 days 1

Special Population: Neonates

• The American Academy of Pediatrics recommends that healthy, term infants with disseminated cutaneous candidiasis require only topical therapy 3, 4, 1
• Premature neonates, low-birth weight neonates, or infants with prolonged rupture of membranes must receive systemic therapy with amphotericin B 0.5-1 mg/kg/day for a total dose of 10-25 mg/kg to prevent progression to lethal invasive candidiasis 3, 4, 1

Special Population: Immunocompromised Patients

• The Infectious Diseases Society of America recommends that patients with neutropenia or severe immunosuppression who develop cutaneous candidiasis may have disseminated disease, and require aggressive systemic antifungal therapy following IDSA guidelines for invasive candidiasis, typically starting with an echinocandin 5, 6
• Up to 13% of patients with invasive disseminated candidiasis develop cutaneous manifestations 5

Prevention of Recurrence

• Maintaining skin dryness, especially in intertriginous areas, and controlling underlying conditions such as diabetes mellitus can help prevent recurrence 1, 2

Common Pitfalls to Avoid

• The American College of Physicians recommends avoiding the use of high-potency topical corticosteroids for extended periods, as they cause skin atrophy and worsen fungal infections 1
• Avoiding occlusive ointments that trap moisture and worsen the condition is also recommended 1

Non-albicans Candida Species

• For infections caused by non-albicans Candida species that don't respond to azoles, the Infectious Diseases Society of America recommends considering alternative topical treatments such as boric acid or topical flucytosine 1
• Fluconazole-resistant yeasts, such as Candida krusei and Candida glabrata, are increasingly common due to widespread azole prophylaxis use 5